These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29944958)

  • 1. Purification and characterization of the antibacterial peptidase lysostaphin from Staphylococcus simulans: Adverse influence of Zn
    Chandra Ojha S; Imtong C; Meetum K; Sakdee S; Katzenmeier G; Angsuthanasombat C
    Protein Expr Purif; 2018 Nov; 151():106-112. PubMed ID: 29944958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Insights into Zn
    Chen K; Ojha SC; Imtong C; Linn AK; Li HC; Thonabulsombat C; Angsuthanasombat C
    Protein Pept Lett; 2021; 28(2):140-148. PubMed ID: 32533816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcus simulans Recombinant Lysostaphin: Production, Purification, and Determination of Antistaphylococcal Activity.
    Boksha IS; Lavrova NV; Grishin AV; Demidenko AV; Lyashchuk AM; Galushkina ZM; Ovchinnikov RS; Umyarov AM; Avetisian LR; Chernukha MIu; Shaginian IA; Lunin VG; Karyagina AS
    Biochemistry (Mosc); 2016 May; 81(5):502-10. PubMed ID: 27297900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved loop residues-Tyr
    Charoenjotivadhanakul S; Sakdee S; Imtong C; Li HC; Angsuthanasombat C
    Biochem Biophys Res Commun; 2023 Aug; 668():111-117. PubMed ID: 37245291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic expression of mature glycylglycine endopeptidase lysostaphin with an amino terminal hexa-histidine in a soluble and catalytically active form in Escherichia coli.
    Sharma R; Sharma PR; Choudhary ML; Pande A; Khatri GS
    Protein Expr Purif; 2006 Jan; 45(1):206-15. PubMed ID: 16181789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-yield production of active recombinant S. simulans lysostaphin expressed in E. coli in a laboratory bioreactor.
    Duman-Özdamar ZE; Ünlü A; Ünal H; Woodley JM; Bi Nay B
    Protein Expr Purif; 2021 Jan; 177():105753. PubMed ID: 32950627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcus aureus mutants with increased lysostaphin resistance.
    Gründling A; Missiakas DM; Schneewind O
    J Bacteriol; 2006 Sep; 188(17):6286-97. PubMed ID: 16923896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.
    Becker SC; Foster-Frey J; Donovan DM
    FEMS Microbiol Lett; 2008 Oct; 287(2):185-91. PubMed ID: 18721148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus.
    Gründling A; Schneewind O
    J Bacteriol; 2006 Apr; 188(7):2463-72. PubMed ID: 16547033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus.
    Sugai M; Fujiwara T; Ohta K; Komatsuzawa H; Ohara M; Suginaka H
    J Bacteriol; 1997 Jul; 179(13):4311-8. PubMed ID: 9209049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Purification of recombinant lysostaphin by monoclonal antibody affinity chromatography].
    Huang J; Wu H; Zhang J; Huang Q
    Sheng Wu Gong Cheng Xue Bao; 2009 Jan; 25(1):147-51. PubMed ID: 19441240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus.
    DeHart HP; Heath HE; Heath LS; LeBlanc PA; Sloan GL
    Appl Environ Microbiol; 1995 Apr; 61(4):1475-9. PubMed ID: 7747966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the antimicrobial peptidase lysostaphin from Staphylococcus simulans.
    Sabala I; Jagielska E; Bardelang PT; Czapinska H; Dahms SO; Sharpe JA; James R; Than ME; Thomas NR; Bochtler M
    FEBS J; 2014 Sep; 281(18):4112-22. PubMed ID: 25039253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient adsorption of lysostaphin on bacterial cells of lysostaphin-resistant Staphylococcus aureus mutant.
    Sakurada J; Murai M; Zhijun L; Usui A; Seki K; Kobayashi K; Sumi Y; Jitsukawa H; Masuda S
    Microbiol Immunol; 1993; 37(1):29-34. PubMed ID: 8474355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New effective sources of the Staphylococcus simulans lysostaphin.
    Szweda P; Kotłowski R; Kur J
    J Biotechnol; 2005 May; 117(2):203-13. PubMed ID: 15823409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural bases of peptidoglycan recognition by lysostaphin SH3b domain.
    Mitkowski P; Jagielska E; Nowak E; Bujnicki JM; Stefaniak F; Niedziałek D; Bochtler M; Sabała I
    Sci Rep; 2019 Apr; 9(1):5965. PubMed ID: 30979923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of Polycations on Antibacterial Activity of Lysostaphin].
    Kulikov SN; Khairullin RZ; Varlamov VP
    Prikl Biokhim Mikrobiol; 2015; 51(6):610-5. PubMed ID: 26859963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specific N-glycosylation of caprine lysostaphin restricts its bacteriolytic activity toward Staphylococcus aureus.
    Huang CY; Hsu JT; Chung PH; Cheng WT; Jiang YN; Ju YT
    Anim Biotechnol; 2013; 24(2):129-47. PubMed ID: 23534959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The choice of chromatographic resin for the purification of recombinant lysostaphin affects its activity.
    Shestak NV; Grishin AV; Lyashchuk AM; Lunin VG; Karyagina AS
    Protein Expr Purif; 2023 Jul; 207():106274. PubMed ID: 37084838
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Raulinaitis V; Tossavainen H; Aitio O; Seppala R; Permi P
    Biomol NMR Assign; 2017 Apr; 11(1):69-73. PubMed ID: 27943001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.